Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 10, 2024
Univo IRB announced that Julie Blasingim has been promoted to CEO by Univo’s board of directors. As CEO, Blasingim will drive Univo IRB’s strategic growth and innovation, bringing a modern iteration of IRB solutions to unify patients and research, ...
read more
Wednesday, September 03, 2025
Julius Clinical, a clinical Contract Research Organization (CRO) with therapeutic expertise in CNS and Cardiometabolic indications, announced continued growth in bookings in these key therapeutic areas during the second quarter of 2025.
read more
Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc., has entered into a long-term collaboration with OxSonics Limited to support the development, scale-up, and GMP manufacturing of OxSonics' proprietary "sono-sensitive particles."
read more
Juniper Pharma Services has broadened its manufacturing capabilities bringing on-line its new spray dryer following the successful installation and validation of the advanced manufacturing equipment at its UK-based site.
read more
Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc., has added a roller compactor to its enabling technologies platform to satisfy increasing market demand for its pharmaceutical development services.
read more
Juniper Pharma Services (JPS), a Contract Development and Manufacturing Organisation (CDMO) specialising in the development of challenging small molecules, has announced a significant expansion to its UK-based drug development and clinical trial ...
read more
Juniper Pharma Services has reinforced its enabling technologies platform by making a substantial investment into its spray drying capabilities.
read more
Tuesday, November 15, 2016
Juniper Pharmaceuticals, a women's health therapeutics company, has entered into an agreement with its partner, Allergan to monetize future royalty payments due to Juniper for U.S. sales of Crinone® (progesterone gel). Under the agreement, Juniper ...
read more
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.
read more
Wednesday, December 06, 2017
Juno Therapeutics announced three license agreements to advance its program in multiple myeloma using GSIs in combination with BCMA-directed CAR T cells.
read more
Juno Therapeutics, a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, ...
read more
Wednesday, January 22, 2020
Evotec announced its wholly-owned Seattle-based subsidiary company Just – Evotec Biologics has established a collaborative relationship with OncoResponse.
read more
Wednesday, September 19, 2018
Just Biotherapeutics and Pandion Therapeutics announced they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.
read more
Just Biotherapeutics announced they have entered into an agreement with Teva for the design and development of a high productivity (HP) biomanufacturing process.
read more
JW Pharmaceutical and LEO Pharma announced they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601.
read more